Home About Us Products R & D Clinical Trials Media Publications Contact Us

PUBLICATIONS > CLINICAL TRIAL PUBLICATION Introduction | R&D Publication | Clinical Trial Publication | Pre-Clinical Trial Publication   Clinical Trial Publications   Authors Title Journal Type Links Mohammad A Ostavan Experience with Paclitaxel-Eluting Infinnium Coronary Stents Asian Cardiovascular & Thoracic Annals Article Joost Daemen A Survey of Current and Future Generation Drug-Eluting Stents: Meaningful Advances or More of the Same? Circulation Article Dr. D.S. Gambhir Biodegradable-polymer-based, paclitaxel-eluting Infinnium™ stent: 9-month clinical and angiographic follow-up results from the SIMPLE II prospective Multicenter registry study. Eurointervention Presentation Pawel Buszman Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: A prospective Multicenter registry Willey InterScience Article Pedro A. Lemos Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-Year results of the PAINT trial Willey InterScience Article Lynne Peterson Summary Trends-in-Medicine Article Sameer Dani Biodegradable-polymer-based, sirolimus-eluting Supralimus® stent: 6-month angiographic and 30 month clinical follow-up results from the Series I prospective study Euro Intervention Presentation Ricardo Costa Complex patients with coronary artery disease treated with the novel supralimus sirolimus-eluting stents. Preliminary results of the prospective, multicenter, non-randomised E-Series trial Euro Intervention Presentation Andrea Abizaid Six-Month Clinical Outcomes of Sirolimus-Eluting Stents with a Biodegradable Polymer for the Treatment of Unselected Patients with Complex Coronary Lesions - Preliminary Results from the Prospective, Multicenter E-Series Registry JACC Presentation Alexander Abizaid Complex patients with coronary artery disease treated with the novel supralimus sirolimus-eluting stents. Preliminary results of the prospective, multicenter, non-randomised E-Series trial Euro Intervention Presentation Pedro A Lemos Biodegradable-polymer Infinnium Paclitaxel-eluting And Supralimus Sirolimus-eluting Stents Reduce Neointimal Proliferation in Patients at Low Risk of Restenosis: Findings From The 3-arm Paint Randomized Controlled Trial Circulation Presentation Marco A Perin Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-Year results of the PAINT trial Catheterization and Cardiovascular Intervention Article Layth Mimish EXPERIENCE WITH INFINNIUM PACLITAXEL DES IN SAUDI ARABIA. Heart View Presentation Neville Kukreja Biodegradable-polymer-based, sirolimus-eluting Supralimus® stent: 6-month angiographic and 30 month clinical follow-up results from the Series I prospective study. Euro Intervention Presentation Jose de Ribamar Costa, Jr. Supralimus™ Bioabsorbable-Polymer Sirolimus-Eluting Stent Technology in Patients with Acute Coronary Syndrome: Two-Year Results of the Prospective, Multicenter, E-Series Registry. JACC Presentation Introduction | R&D Publication | Clinical Trial Publication | Pre-Clinical Trial Publication

Home  |  About Us  |  Products  |  R & D  |  Clinical Trials  |  Media  |  Publications  |  Contact Us  |  Site Map  |  Privacy Policy Sahajanand Medical Technologies Pvt. Ltd. - "Sahajanand Estate", Wakhariawadi, Nr. Dabholi Char Rasta, Ved Road, Surat - 395004 (Guj.), India Tel: +91-261-3060606 Fax: +91-261-3060607 © Copyright 2008. All rights reserved. Last Update: 2008/05/14